100 results
8-K
EX-10.1
k8z2kl24o4o
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
424B3
961850ox
14 Jan 21
Prospectus supplement
5:11pm
S-4/A
EX-10.24
akvxdt 1y0uwo0p9ln9x
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
p937 g9mmkh
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
EX-10.25
twz0figac p0rmvs
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4
4rzcknqc2mj0r
22 Dec 20
Registration of securities issued in business combination transactions
6:24am